iodofiltic acid has been researched along with dobutamine in 9 studies
Studies (iodofiltic acid) | Trials (iodofiltic acid) | Recent Studies (post-2010) (iodofiltic acid) | Studies (dobutamine) | Trials (dobutamine) | Recent Studies (post-2010) (dobutamine) |
---|---|---|---|---|---|
551 | 66 | 56 | 6,357 | 818 | 1,011 |
Protein | Taxonomy | iodofiltic acid (IC50) | dobutamine (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Homo sapiens (human) | 4.17 | |
Epidermal growth factor receptor | Homo sapiens (human) | 5.551 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 5.519 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 3.975 | |
Beta-2 adrenergic receptor | Homo sapiens (human) | 1.517 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.383 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 1.944 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 0.599 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 2.966 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.383 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.114 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.895 | |
D(3) dopamine receptor | Homo sapiens (human) | 4.985 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.155 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 2.518 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Block, P; Bossuyt, A; De Geeter, F; Demoor, D; Dendale, P; Franken, PR | 2 |
de Roos, A; Dendale, P; Franken, PR; van der Wall, EE | 1 |
Dobbeleir, A; Hambye, AS; Vervaet, A | 1 |
Fujiwara, S; Nitobe, J; Takahashi, K; Takeishi, Y; Tojo, T; Tomoike, H; Yamaoka, M | 1 |
Azakami, S; Hiroki, T; Homma, T; Koyanagi, S; Matsumoto, T; Ohzono, K; Sakai, K; Sako, S; Yasugi, N | 1 |
Bax, JJ; Eersels, J; Knapp, FF; Poldermans, D; Sloof, GW; van Lingen, A | 1 |
Akutsu, Y; Hamazaki, Y; Katagiri, T; Kayano, H; Kodama, Y; Li, HL; Shinozuka, A; Yamanaka, H | 1 |
Fujibayashi, Y; Fujita, M; Hirai, T; Hosokawa, R; Kambara, N; Kimura, T; Kita, T; Nohara, R; Ohba, M; Tadamura, E | 1 |
2 trial(s) available for iodofiltic acid and dobutamine
Article | Year |
---|---|
Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve.
Topics: Coronary Angiography; Dobutamine; Echocardiography; Fatty Acids; Fatty Acids, Nonesterified; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Sensitivity and Specificity; Streptokinase; Technetium Tc 99m Sestamibi; Thrombolytic Therapy; Tomography, Emission-Computed, Single-Photon | 1994 |
Fatty acid imaging with 123I-15-(p-iodophenyl)-9-R,S-methylpentadecanoic acid in acute coronary syndrome.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Dobutamine; Echocardiography; Fatty Acids; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Infarction; Myocardium; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1999 |
7 other study(ies) available for iodofiltic acid and dobutamine
Article | Year |
---|---|
Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy.
Topics: Coronary Angiography; Dobutamine; Echocardiography; Fatty Acids; Female; Follow-Up Studies; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Predictive Value of Tests; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Time Factors; Ventricular Function, Left | 1996 |
Wall thickening at rest and contractile reserve early after myocardial infarction: correlation with myocardial perfusion and metabolism.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Circulation; Dobutamine; Evaluation Studies as Topic; Fatty Acids; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors | 1997 |
Quantification of 99Tcm-sestamibi and 123I-BMIPP uptake for predicting functional outcome in chronically ischaemic dysfunctional myocardium.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Artery Bypass; Dobutamine; Echocardiography; Fatty Acids; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Ventricular Dysfunction, Left | 1999 |
Comparative study of dobutamine stress echocardiography and dual single-photon emission computed tomography (thallium-201 and I-123 BMIPP) for assessing myocardial viability after acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Dobutamine; Echocardiography, Stress; Fatty Acids; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Recovery of Function; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed, Single-Photon | 2002 |
Nuclear imaging is more sensitive for the detection of viable myocardium than dobutamine echocardiography.
Topics: Coronary Artery Disease; Dobutamine; Echocardiography; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Iodobenzenes; Middle Aged; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Usefulness of simultaneous evaluations of contractile reserve, perfusion, and metabolism during dobutamine stress for predicting wall motion reversibility (myocardial stunning) after successful PTCA.
Topics: Aged; Angioplasty, Balloon, Coronary; Dobutamine; Echocardiography, Stress; Fatty Acids; Fatty Acids, Nonesterified; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Recovery of Function; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2004 |
Myocardial metabolism of 123I-BMIPP under low-dose dobutamine infusion: implications for clinical SPECT imaging of ischemic heart disease.
Topics: Animals; Dobutamine; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Fatty Acids; Image Enhancement; Infusions, Intra-Arterial; Iodobenzenes; Male; Metabolic Clearance Rate; Myocardial Ischemia; Myocardial Stunning; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |